Sources of MERS Still Unknown

As the death toll rises, scientists scour the Middle East respiratory syndrome coronavirus genome for clues as to how it first infected humans.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAIDThe World Health Organization last week announced 18 new laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including three deaths. From September 2012 to date, the CoV has infected 132 people worldwide, killing 58 of them. As scientists continue to investigate the etiology and epidemiology of MERS, others are scouring the CoV genome for clues to its deadly potential and how it first infected humans.

In a report published last week (September 20) in The Lancet, researchers from the Saudi Arabian Ministry of Health and their international colleagues examined the viral genomes from 21 MERS cases, and analyzed the phylogenetic relationships among them, plus nine already published MERS-CoV genome sequences. Their analysis hinted at multiple chains of infection in humans, suggesting that in one particular outbreak—the Al-Hasa cluster—the MERS-CoV might have been introduced to people more than once. Further, the researchers found evidence to suggest that additional human or animal cases, which have gone undetected to date, may be sources of infection.

“The hypothesis now is [that] there were multiple introductions into the hospitals from the community, which gives us the clue that there is probably a community source of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies